ADHD affects about 5–7% of children and adolescents and 2–5% of adults. Although it is generally considered a childhood disorder, symptoms persist into adulthood for the majority of those affected. Medication remains a cornerstone of treatment, with stimulants considered the standard of care. However, non-stimulant therapies remain important alternatives.
Autoren
- Aneta Dehn
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Viloxazine for ADHD
A non-stimulating option—but with limited evidence
- Preclinical study on phytotherapeutic agent
Active ingredient combination of peppermint and caraway oil modified fecal microbiota
- Casuistry
Rituximab used effectively against IgG4-RD colitis
- Sarcoidosis
New options from JAKi to mTOR
- Head and neck squamous cell carcinoma
Precision immunotherapy and local treatment
- From symptom to diagnosis
Abdominal pain – Prostate cysts
- Multimodal Parkinson's Treatment
Positive Effects of a Music-Based Intervention
- Psychooncology